TIFFANY COLBORN: Open Payments
NPI 1982344214 · HERRIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 52 payments from 10 companies in 2025. Trend: 2023 $441 · 2024 $946 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $381 |
| AstraZeneca Pharmaceuticals LP | 3 | $146 |
| Dexcom, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $46 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: VRAYLAR, FARXIGA, UBRELVY, Dexcom G6 Transmitter, REXULTI, VOQUEZNA, BREZTRI, MOUNJARO.
Industry payments across IL — which companies pay providers there.
